Express News | Spero Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
Spero Therapeutics: Board Grants 116,667 Restricted Stk Unit Awards to New Employee >SPRO
Press Release: Spero Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Spero Therapeutics to Participate in H.C. Wainwright Annual BioConnect Investor Conference
Express News | HC Wainwright & Co. Reiterates Buy on Spero Therapeutics, Maintains $7 Price Target
Spero Therapeutics Analyst Ratings
Buy Rating Affirmed for Spero Therapeutics Amidst Drug Pipeline Progress and Strategic Partnerships
Analysts Conflicted on These Healthcare Names: Spero Therapeutics (SPRO) and Coherus Biosciences (CHRS)
Spero Therapeutics Q1 2024 GAAP EPS $(0.24) Misses $(0.04) Estimate, Sales $9.267M Miss $21.533M Estimate
Earnings Flash (SPRO) SPERO THERAPEUTICS Reports Q1 Revenue $9.3M
Spero Therapeutics | 10-Q: Quarterly report
Express News | Spero Therapeutics Inc: Spr720 Top-Line Data From Phase 2a Proof-of-Concept Clinical Trial Are Expected in 2H 2024
Express News | Spero Therapeutics Inc: Received FDA Fast Track Designation for Spr206 for Treatment of Habp/Vabp Due to Crabc and Crpa
Express News | Spero Therapeutics Inc: Reiterate Expected Cash Runway Into Late 2025
Express News | Spero Therapeutics Announces First Quarter 2024 Operating Results and Provides a Business Update
Press Release: Spero Therapeutics Announces First Quarter 2024 Operating Results and Provides a Business Update
Spero Therapeutics 1Q Loss/Shr 24c >SPRO
Spero Therapeutics 1Q Rev $9.27M >SPRO
Notable Earnings After Wednesday's Close
Shareholders in Spero Therapeutics (NASDAQ:SPRO) Are in the Red If They Invested Three Years Ago